StopDown
Funding · 17 September 2024Redcliffe Labs$42MOmnichannel diagnostics service providerredcliffelabs.com ↗

Redcliffe Labs raises $42M in Series C funding

By · Editor ·

Series C
  • Redcliffe Labs is an omnichannel diagnostics service provider with 80+ labs and 2,000+ collection centres
  • It raised $42M in Series C funding led by IFU, with participation from LeapFrog Investments, HealthQuad and Spark Growth Ventures
  • The company plans to expand into Tier-II and Tier-III cities and pursue pan-India growth through acquisitions and partnerships

What happened

  • Redcliffe Labs raised $42M in Series C funding.
  • The round was led by IFU (Denmark's Investment Fund for Developing Countries) with $20M.
  • Existing investor LeapFrog Investments contributed $15M.
  • Other existing shareholders HealthQuad and Spark Growth Ventures provided the remaining capital.
  • The company will use the funds to open more labs and collection centres and expand its home collection network.
  • It aims to deepen its presence in Tier-II and Tier-III cities across India.
  • Redcliffe Labs is pursuing pan-India expansion through strategic partnerships and further acquisitions.
  • The company has already made acquisitions in north-western India.

Why it matters

  • The Indian diagnostics sector is at an inflection point with significant growth opportunities.
  • Redcliffe Labs aims to democratise access to affordable, accurate diagnostics for every Indian, especially underserved populations.
  • The company's operating revenue grew 2.6x to Rs 347 crore in FY23, though losses widened to Rs 345.6 crore.
  • This funding follows a $61M Series B round in May 2022 and a $10M Series A in April 2021.

The business

  • Redcliffe Labs is an omnichannel diagnostics service provider offering health checkup packages, individual tests, smart reports with colour-coded insights, expert consultation, AI assistance and diet plans.
  • It operates 80+ labs, 2,000+ collection centres and provides home collection services with over 1,000 phlebotomists.
  • The company serves 220+ cities across India and has served over 7 million patients.
  • It has launched Femcliffe, India's first she-centric diagnostic platform, and GeneCliffe for DNA, chromosome and protein testing.
  • Redcliffe Labs holds NABL accreditation and follows Six Sigma practices.

The founders

Aditya Kandoi

Founder and CEO
in

Who put in money

  • IFU (Denmark's Investment Fund for Developing Countries) lead — Denmark's development finance institution investing in private companies in developing countries.
  • LeapFrog Investments existing — A global impact investor focused on healthcare and financial services in emerging markets.
  • HealthQuad existing — A healthcare-focused venture capital fund.
  • Spark Growth Ventures existing — An early-stage venture capital firm.

In numbers

Rs 347 croreOperating revenue · FY23
Rs 130 croreOperating revenue · FY22
Rs 345.6 croreLosses · FY23
Rs 67.7 croreLosses · FY22
80+Labs · 2024
2,000+Collection centres · 2024
220+Cities served · 2024
7 million+Patients served · 2024

What happens next

  • Open more labs and collection centres.
  • Expand home collection network.
  • Deepen presence in Tier-II and Tier-III cities.
  • Pursue pan-India expansion through strategic partnerships and further acquisitions.

Earlier rounds

  • 2022-05 · Series B · $61M
  • 2021-04 · Series A · $10M

Up against

PharmEasy-owned ThyrocareHealthians1mgDr. Lal PathLabs

Words to know

Series C
A later-stage funding round for companies that have already proven their business model and are scaling operations.
Omnichannel
Providing services through multiple channels (online and offline) seamlessly.
NABL accreditation
National Accreditation Board for Testing and Calibration Laboratories, a quality standard for diagnostic labs in India.
Six Sigma
A set of techniques for process improvement, aiming for near-perfect quality (fewer than 3.4 defects per million opportunities).

The numbers around it

Redcliffe Labs has 4 funding rounds in StopDown's archive, $115 Mn raised in all.

#The numbers around it
WhenRoundAmountLed by
13 August 2023growth$80 million
29 September 2022Series B$100-125 million
6 May 2022Series B$61MLeapFrog Investments

Other articles talking about it

Read it as a card in the app

Terms in this story

  • Tier-2 startups: A growing share of Indian startups now come from tier-2 and tier-3 cities and towns, helped by cheap data, lower costs and local problems that big-city founders do not see. Raising money and hiring senior talent remain the main hurdles.
  • Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
  • Series B/C: Series B, C, D and later rounds are growth rounds: large cheques for a startup with a proven model that wants to expand, enter new markets or move toward profit and a listing. In India they are usually priced in CCPS and, when foreign investors take part, must follow FEMA pricing rules.
  • Lead investor: A lead investor is the investor that sets the price and main terms of a funding round, does the deepest checks on the company and usually puts in the largest cheque. When a headline says a round was led by a fund, that fund was the first to commit and shaped the deal that others joined.

Everything on Redcliffe Labs → · All startup news on 17 September 2024 →

Is this Redcliffe Labs? Get your “Featured on StopDown” badge →